IRADIMED CORPORATION IRMD
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -21.18%
- 1 year
- +0.34%
- Open
- 82.28
- Prev close
- 85.74
- Mkt cap
- 980.51M
- Vol
- 218.00K
- Avg vol
- 123.88K
- EPS
- 1.79
- P/E
- 42.84
- Div yield
- 0.95%
More statistics
- Low
- 76.35
- High
- 82.28
- Forward P/E
- 34.95
- Beta
- 0.91
- Short ratio
- 5.23
- Inst. own
- 62.45%
- Dividend
- 0.80
- Ex-div date
- Aug 13, 2026
- Earnings
- Oct 30, 2026
- 50-d avg
- 85.89
- 200-d avg
- 92.73
- 1y target
- 118.00
5D chart
Events in this range
- Oct 30, 2026Earnings: —; estimate 0.55; surprise —%
Signals (109)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 1:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:55 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 10:50 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:45 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:30 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:15 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:35 PM | 3 days ago |
| RSI: Oversold | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:00 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:30 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:35 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:25 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:25 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 5 days ago |
| RSI: Oversold | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:25 AM | 5 days ago |
| RSI: Oversold | Oct 27, 10:25 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:45 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:45 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:40 AM | 5 days ago |
| RSI: Oversold | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:45 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:45 PM | 6 days ago |
| RSI: Oversold | Oct 26, 2:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:00 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:00 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:50 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:45 AM | 6 days ago |
News
2 days ago marketbeat.com
What iRadimed (IRMD) Said on Its Q3 Earnings Call
iRadimed NASDAQ: IRMD reported record third-quarter revenue as shipments of its newly launched 3870 MR IV pump accelerated, while the company said it is moderating its production ramp to protect…
2 days ago seekingalpha.com
IRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript
IRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript
2 days ago benzinga.com
iRadimed Q3 2026 Earnings Call Transcript
iRadimed (NASDAQ:IRMD) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
-
2 days ago benzinga.com
iRadimed Q3 Adj. EPS $0.55, Inline, Sales $24.203M Beat $23.467M Estimate
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.55 per share which met the analyst consensus estimate. This is a 17.02 percent increase over earnings of $0.47 per share from the same period…
-
2 days ago benzinga.com
iRadimed Lowers FY2026 Adj EPS Guidance from $2.09-$2.24 to $2.07-$2.11 vs $2.11 Est; Narrows FY2026 Sales Guidance from $91.000M-$96.000M to $91.600M-$93.100M vs $92.133M Est
iRadimed (NASDAQ:IRMD) lowers FY2026 Adj EPS guidance from $2.09-$2.24 to $2.07-$2.11 vs $2.11 analyst estimate. Narrows FY2026 sales outlook from $91.000 million-$96.000 million to $91.600…
-
2 days ago benzinga.com
iRadimed Sees Q4 Adj EPS $0.57-$0.61 vs $0.63 Est; Sees Sales $25.000M-$26.500M vs $26.233M Est
iRadimed (NASDAQ:IRMD) is looking for Q4 Adj EPS of $0.57-$0.61 vs $0.63 analyst estimate. sees sales of $25.000 million-$26.500 million vs $26.233 million analyst estimate.
2 days ago globenewswire.com
IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results
Reports revenue of $24.2 million for the third quarter of 2026, which increased by $3.0 million, or 14% compared to the same period in 2025 and increased by $3.7 million or 18% compared to the second…
4 days ago seekingalpha.com
Riverwater Small Cap Strategy Q3 2026 Portfolio Update
During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors…
6 days ago defenseworld.net
iRadimed (IRMD) Expected to Post Earnings on Friday
iRadimed (NASDAQ: IRMD - Get Free Report) is expected to be posting its Q3 2026 results before the market opens on Friday, October 30th. Analysts expect the company to announce earnings of $0.55 per…
1 week ago globenewswire.com
IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026
ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 third quarter financial results before the market opens on…
1 month ago globenewswire.com
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
ORLANDO, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices,…
1 month ago defenseworld.net
Head-To-Head Contrast: iRadimed (NASDAQ:IRMD) & Medline (NASDAQ:MDLN)
iRadimed (NASDAQ: IRMD - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on…
1 month ago gurufocus.com
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100
On September 04, 2026, iRadimed Corp (IRMD) shares fell 3.8%, currently trading at $83.45. The stock has seen a notable decline, with a 52-week high of $107.90
2 months ago defenseworld.net
Algert Global LLC Sells 15,062 Shares of iRadimed Corporation $IRMD
Algert Global LLC trimmed its stake in iRadimed Corporation (NASDAQ: IRMD) by 17.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
2 months ago defenseworld.net
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of iRadimed Corporation (NASDAQ: IRMD - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five ratings firms that are presently covering the firm, MarketBeat…
3 months ago marketbeat.com
iRadimed Q2 Earnings Call Highlights
iRadimed NASDAQ: IRMD reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked…
3 months ago seekingalpha.com
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
-
3 months ago benzinga.com
iRadimed Sees Q3 Adj EPS $0.54-$0.59 vs $0.52 Est; Sees Sales $23.000M-$24.500M vs $23.650M Est
iRadimed (NASDAQ:IRMD) is looking for Q3 Adj EPS of $0.54-$0.59 vs $0.52 analyst estimate. sees sales of $23.000 million-$24.500 million vs $23.650 million analyst estimate.
-
3 months ago benzinga.com
CORRECTION: iRadimed Raises FY2026 Adj EPS Guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $91.300M Est
iRadimed (NASDAQ:IRMD) raises FY2026 Adj EPS guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 analyst estimate. Raises FY2026 sales outlook from $91.000 million-$96.000 million to $91.000…
3 months ago globenewswire.com
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by…
3 months ago globenewswire.com
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on…
3 months ago benzinga.com
Elon Musk Confirms Starlink Can Deliver Reliable 10 Gigabit-a-Second Upload and Download Speeds Anywhere On Earth
Elon Musk announced Starlink can now provide 10 Gbps global connectivity, a key step in satellite internet's push to high-speed data service.
5 months ago fool.com
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
This medical device maker, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year stock performance.
5 months ago globenewswire.com
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and…
6 months ago fool.com
Why Iradimed Stock Topped the Market Today
Yet again, it posted growth and robust profitability in its latest quarter.
6 months ago gurufocus.com
iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Tells Investors
On May 01, 2026, iRadimed Corp (IRMD) shares rose 4.4%, bringing the current price to $87.15. This movement comes amid a 52-week range that has seen a high of $
6 months ago seekingalpha.com
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
-
6 months ago benzinga.com
iRadimed Affirms FY2026 Adj EPS Guidance of $2.06-$2.21 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $92.346M Est
iRadimed (NASDAQ:IRMD) affirms FY2026 Adj EPS guidance from $2.06-$2.21 to $2.06-$2.21 vs $2.08 analyst estimate. Affirms FY2026 sales outlook from $91.000 million-$96.000 million to $91.000…
-
6 months ago benzinga.com
iRadimed Sees Q2 Adj EPS $0.44-$0.48 vs $0.47 Est; Sees Sales $20.000M-$21.000M vs $21.134M Est
iRadimed (NASDAQ:IRMD) is looking for Q2 Adj EPS of $0.44-$0.48 vs $0.47 analyst estimate. sees sales of $20.000 million-$21.000 million vs $21.134 million analyst estimate.
-
6 months ago benzinga.com
iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.45 by 8.89 percent. This is a 16.67 percent increase over earnings of $0.42 per…
8 months ago benzinga.com
Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday
Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday
-
8 months ago benzinga.com
iRadimed Raised Its Quarterly Dividend To $0.20/Share From $0.17/Share
IRADIMED CORPORATION (the "Company" or "Iradimed") (NASDAQ:IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing…
8 months ago benzinga.com
iRadimed Q4 Earnings Summary & Key Takeaways
iRadimed Q4 Earnings Summary & Key Takeaways
-
8 months ago benzinga.com
Earnings Scheduled For February 10, 2026
Earnings Scheduled For February 10, 2026
8 months ago benzinga.com
Uncovering Potential: iRadimed's Earnings Preview
Uncovering Potential: iRadimed's Earnings Preview
-
10 months ago benzinga.com
iRadimed Declares $0.50/Share Special Cash Dividend Payable December 30, 2025
iRadimed Corporation (the "Company") (NASDAQ:IRMD), announced that its Board of Directors (the "Board") approved a special cash dividend of $0.50 per share of the Company's outstanding common stock.…
-
12 months ago benzinga.com
iRadimed Sees Q4 Adj EPS $0.47-$0.51 vs $0.47 Est; Sees Sales $21.400M-$22.400M vs $20.733M Est
iRadimed (NASDAQ:IRMD) is looking for Q4 Adj EPS of $0.47-$0.51 vs $0.47 analyst estimate. sees sales of $21.400 million-$22.400 million vs $20.733 million analyst estimate.
-
12 months ago benzinga.com
iRadimed Raises FY2025 Adj EPS Guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 Est; Raises FY2025 Sales Guidance from $80.000M-$82.500M to $82.500M-$83.500M vs $81.091M Est
iRadimed (NASDAQ:IRMD) raises FY2025 Adj EPS guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 analyst estimate. Raises FY2025 sales outlook from $80.000 million-$82.500 million to $82.500…
-
12 months ago benzinga.com
iRadimed Q3 Adj. EPS $0.47 Beats $0.46 Estimate, Sales $21.202M Beat $20.498M Estimate
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.46 by 3.3 percent. This is a 9.3 percent increase over earnings of $0.43 per…
12 months ago benzinga.com
Earnings Scheduled For November 3, 2025
Earnings Scheduled For November 3, 2025
-
1 year ago benzinga.com
Earnings Scheduled For February 13, 2025
Earnings Scheduled For February 13, 2025
-
2 years ago benzinga.com
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
-
2 years ago benzinga.com
Earnings Scheduled For November 3, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
-
3 years ago benzinga.com
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
-
3 years ago benzinga.com
Earnings Scheduled For May 4, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
-
3 years ago benzinga.com
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.